The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Bayer and Rad AI have announced a new partnership at the SIIM conference focusing on integrating Rad AIs AIdriven radiology operational solutions into Bayers Calantic Digital Solutions platform Rad AI provides advanced technologies like radiology spe...
ReCode Therapeutics announced today that the US Food and Drug Administration has granted Orphan Drug Designation to RCT for the treatment of primary ciliary dyskinesia This genetic disease
Skyhawk Therapeutics Inc a clinicalstage biotech company focused on developing innovative small molecule therapies that target critical RNA molecules has announced its expansion
InDevR Inc a leader in vaccine analytical solutions has introduced CapQ a new kit designed for rapid determination of mRNA capping efficiency This solution part of the VaxArray Platform
ProBio Inc a prominent contract development and manufacturing organization based in New Jersey has inaugurated a stateoftheart facility in Hopewell New Jersey aimed at expanding its capabilities
Navamedic ASA and Orion Corporation have signed an exclusive license and supply agreement for Flexilev and its OraFID dispenser in most of Europe excluding Sweden Norway Denmark and Iceland
Biogen Inc has received approval from the European Commission for TOFIDENCE a biosimilar monoclonal antibody referencing ROACTEMRA This intravenous formulation
EG a leading biotechnology company has received FDA clearance for clinical trials of EGA a gene therapy targeting Neurogenic Bladder NDO in spinal cord injury SCI patients This therapy utilizes
AriBio Co Ltd has announced a strategic collaboration with Kentucky Clinical Trial Laboratory to expand Alzheimers disease testing This partnership focuses on utilizing the Lumipulse system from FujireBio
The US Food and Drug Administration recently expanded its approval of Elevidys a gene therapy for Duchenne muscular dystrophy to include ambulatory and nonambulatory individuals aged years and older with a confirmed mutation in the DMD gene Initiall...
